Brief: Index Pharmaceuticals Q1 Operating Loss Widens To SEK 24.0 Mln
May 7 (Reuters) - InDex Pharmaceuticals Holding AB
INDEX.ST :
* Q1 OPERATING LOSS AMOUNTED TO SEK -24.0 (-17.2) MILLION
Source text for Eikon: ID:nWkr5q98vk
Further company coverage: INDEX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Flerie AB
See all newsBrief: Flerie Q3 Net Asset Value SEK 3,113 Million
Brief: Flerie Portfolio Co Reports Positive Data From Clinical Proof-Of-Mechanism Study
Brief: Flerie Writes Down Value Of Holding In Empros Pharma
Brief: Nasdaq Approves Biosergen's Delisting Application
Brief: Flerie Approves Merger Plan For Flerie And Biosergen